… Combined, these cellular attributes characterize T cells with antitumor properties that may
… IL4, IL5, and IL13 were detected in response to peptide-pulsed T2 cells but not to control T2 …

… strategy to enhance T cell–targeted immunotherapy. … of synthetic CDNs that activate STING
stimulates antitumor … into the induction of IFNs by antigen-presenting cells, we treated bone …

… -specific T cell responses in a non-artificial mouse model. … recognized by T cells in the context
of antigen-presenting molecules… with CD4 + T cell-targeted vaccine shows better antitumor …

… Different approaches using antibodies, natural or synthetic ligands… effectively elicited a robust
and protective immune response … as a model to elicit an antitumoral response in dogs. The …

… synthetic vaccines can be engineered to enhance MHC-I presentation of exogenous peptide
and protein antigens by professional antigen-presenting cells (… + T cell‐targeted vaccines. …

… Immunization with synthetic mRNA encoding tumor-… antigen-presenting cells antigen
presentation, and induce an … a more effective protective antitumor effect. Furthermore, our …

… of synthetic particles enable artificial antigen-presenting cell (… to CD4+ T-cells and regulate
effector responses through only … to provide longer term protection against lupus. Furthermore, …

… immune responses at nanogram dosing. Along with CoPoP (… better taken up by antigen-presenting
cells, where they were … protection rate is in accordance to the Ag-specific CD8 + T …

… T cell targeted nanoparticles have been formulated to act as tolerogenic artificial antigen
presenting cells… viruses and pathogens that elicit or subvert immune responses are, in essence, …

… delivery to antigen presenting cells to elicit enhanced broadly protective immune responses.
… mRNA vaccine to antigen-presenting cells (APCs) especially dendritic cells, we designed …